Natalie Berry, Tim Gardner, Isobelle Anderson: October 2015 | The Health Foundation
On targets: How targets can be most effective in the English NHS explores how national targets can be used most effectively to improve the quality of care provided by the NHS in England. It builds on what is known about the impact of targets to identify good practice in designing and implementing new or improved targets.
This report was informed by a review of existing evidence, research into public attitudes and engagement with clinicians and managers from across the NHS and from national organisations including those with expertise in setting, managing and reviewing targets.
- National bodies involved in setting and managing targets must urgently develop a collective understanding about how current targets fit with their vision for the NHS over the next 5-10 years. Reviewing and potentially changing existing NHS performance targets will require strong political leadership.
- Before deciding on a new national target, policymakers must consider whether it is the most appropriate means of achieving the desired outcome. Our report identifies five factors whose presence will increase the likelihood of targets effectively improving performance.
- Any new target should be designed pragmatically (to manage gaps that may exist in the evidence base), collaboratively (with both patients and health care professionals) and iteratively (informed by regular review and adapted over time as necessary). The Health Foundation’s feedback loop model provides a framework to support policymakers in keeping new and existing targets under review.
- To implement targets effectively, policymakers should focus less on penalties and more on supporting local commissioners and providers to develop the capacity and capability to make sustainable improvement. The creation of NHS Improvement provides an opportunity to refresh the approach to target management.
via On targets: How targets can be most effective in the English NHS | The Health Foundation.
Provisional monthly figures for headcount, full-time equivalent, role count and turnover of NHS Hospital and Community Health Service (HCHS) staff groups working in England (excluding primary care staff).
As expected with provisional statistics, some figures may be revised from month to month as issues are uncovered and resolved. No refreshes of the provisional data will take place either as part of the regular publication process, or where minor enhancements to the methodology have an insignificant impact on the figures at a national level.
However, the provisional status allows for this to occur if it is determined that a refresh of data is required subsequent to initial release. Where a refresh of data occurs, it will be clearly documented in the publications.
The monthly publication is an accurate summary of the validated data extracted from the NHS’s HR and Payroll system. It has a provisional status as the data may change slightly over time where trusts make updates to their live operational systems.
Given the size of the NHS workforce and the changing composition, particularly during this period of transition, it is likely that we will see some additional fluctuations in the workforce numbers over the next few months, reflecting both national and local changes as a result of the NHS reforms.
These statistics relate to the contracted positions within English NHS organisations and may include those where the person assigned to the position is temporarily absent, for example on maternity leave.
Find more via Find data – Health & Social Care Information Centre.
The Lancet: Volume 386, No. 10004, p1600, 24 October 2015
Dementia resulting from Alzheimer’s disease has catapulted into the public’s consciousness in the past few years. However, dementia has many causes—not just Alzheimer’s, and the symptoms of non-Alzheimer’s dementias can be very different. A three-paper Series in The Lancet summarises the most common non-Alzheimer’s disorders that cause dementia. In the first, Jee Bang and colleagues discuss frontotemporal dementia. The disorder has three variants: behavioural-variant, associated with behavioural deficits; non-fluent variant primary progressive aphasia, with language deficits; and semantic-variant primary progressive aphasia, a disorder of semantic knowledge and naming.
Non-Alzheimers dementia: The Lancet, Published: October 23, 2015
Non-Alzheimer’s dementias remain relatively unknown and often poorly diagnosed. More research is needed, not only for effective pharmacological interventions with disease-modifying effects, but also better differential diagnostic techniques to ensure the proper management and care of patients. A Series of three papers summarises the most common non-Alzheimer’s disorders that cause dementia: frontotemporal, Lewy body, and vascular. Read more
- Jee Bang, Salvatore Spina, Bruce L Miller. Frontotemporal dementia. The Lancet, Volume 386, Issue 10004, 24–30 October 2015, Pages 1672-1682
- Zuzana Walker, Katherine L Possin, Bradley F Boeve, Dag Aarsland. Lewy body dementias. The Lancet, Volume 386, Issue 10004, 24–30 October 2015, Pages 1683-1697
- John T O’Brien, Alan Thomas. Vascular dementia. The Lancet, Volume 386, Issue 10004, 24–30 October 2015, Pages 1698-1706
via Dementia—not all about Alzheimer’s – The Lancet.
The Nuffield Trust has launched a five-year strategy outlining how they will work with and support those leading change in the NHS. The Nuffield Trust will:
The National Audit office has published The management of adult diabetes services in the NHS: progress review. This report shows that progress has been made in reducing the additional risk of death for people with diabetes and the additional risk of diabetes-related complications has been stable or has reduced for most complications. However, it estimates there are still 22,000 people dying each year from diabetes-related causes that could potentially be avoided.
By Dasha Kiper | The Guardian
In November 2010, when I was 25 years old, I moved in with a man who was 98. This man, whom I’ll call Mr Schecter, wasn’t a friend or relation or anyone I knew. He was a Holocaust survivor in the first stages of dementia, and I’d been hired to look after him. Although my background was in clinical psychology, I was by no means a professional caregiver. I was employed because Mr Schecter’s son – I’ll call him Sam – had seriously underestimated his father’s condition. Sam’s mistake was understandable. The most obvious paradox of dementia is the victim’s frequent inability to recognise it, and Mr Schecter went about his life as though burdened by the normal aches and pains of aging rather than by an irrevocable and debilitating illness. If he put the laundry detergent in the oven or forgot which floor he lived on, he’d shake his head and sigh, Mayn kop arbet nisht(“my head doesn’t work”). But it was a lament, not a diagnosis. And this denial, both clinical and profoundly human, led Sam to misjudge the illness as well.
Mr Schecter lived in a two-bedroom apartment on a pleasant, tree-lined street in the Bronx. For a man nearing 100, he was amazingly spry. Short, solidly built, with a firm handshake, Mr Schecter exhibited at our first meeting all the hallmarks of dementia. He repeated himself, his mind wandered, and he asked the same questions over and over. He also insisted that he didn’t need help, that he still went to work (he had, of course, stopped), and that if I rented a room from him, it would be on a month-by-month basis. More than anything else, he wanted me to understand that he had agreed to the arrangement only as a concession to his son.
Carry on reading via The deviousness of dementia | Dasha Kiper | Society | The Guardian.
Generic prescribing has made great savings for the NHS, but John Appleby warns that reproducing this success is not likely to provide a quick fix for current financial woes
Over the past 30 years there has been a remarkable change in the prescribing patterns of general practitioners. With the NHS facing a further five years of squeezed funding, and evidence of widespread overspending in the first quarter of this year as NHS providers attempt to meet growing demands,1 2 could the switch GPs have made to generic prescribing hold lessons for the productivity challenge the NHS faces?
Since the mid-1970s spending on primary care prescribing in the English NHS has grown fourfold in real terms—to £8.1bn in 2014-15 (fig 1⇓). This partly reflects the growth in the volume of prescribed items overall—from 285 million in 1976 to just over 1 billion in 2014-15.3 4 5 6 But it also reflects a change in the type of medicines prescribed and dispensed, and changes in their prices.
A key change has been the switch away from proprietary drugs still under patent to cheaper (but chemically identical) generic medicines.
Carry on reading via The rise and rise of generic prescribing | The BMJ.